| Subject: | Palladone (hydromorphone hydrochloride) Withdrawn from the Market |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 1 Aug 2005 - 10:00 am |
| The StayAlert Administrator has learned that Purdue Pharma, L.P., at the request of the FDA, has withdrawn Palladone (hydromorphone hydrochloride) extended release capsules from the market. Serious and potentially fatal adverse reactions can occur when Palladone extended release capsules are taken together with alcohol.
Palladone is a once-a-day pain management drug containing a very potent narcotic. New data gathered from a company-sponsored study testing the potential effects of alcohol use... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
